National and Kapodistrian University of Athens
Αξιολόγηση της επίδρασης της ερυθροποιητίνης στην ταχύτητα της αποκατάστασης του αιματοκρίτη μετά από οξεία αιμορραγία του άνω πεπτικού
Abstract
dc:descriptionAIM: Anaemia caused by acute upper gastrointestinal bleeding is treated with blood transfusion or iron, but patients usually face a two-month recovery period from post-haemorrhage anaemia. This prospective, randomised, open, study was designed to investigate whether recombinant human erythropoietin (Epoetin) therapy accelerates haematocrit increase in the post-bleeding recovery period. METHODS: We studied hospitalised patients admitted because of acute ulcer bleeding or haemorrhagic gastritis, who had a haematocrit of 27-33% and did not receive blood transfusions. Patients were randomised either to erythropoietin (20.000 IU Epoetin alfa subcutaneously, on days 0, 4 and 6) plus iron (100 mg im, on days 1-6, (group A) or iron only (group B). Haematocrit was measured on days 0, 6, 14, 30, 45 and 60, respectively. RESULTS: One patient from group A and two from group B were lost to follow-up. Therefore, 14 and 13 patients from groups A and B respectively were analysed. Demographic characteristics, serum iron, ferritin, total iron binding capacity, reticulocytes, and haematocrit were not significantly different at study entry. Median haematocrit on day fourteen [group A: 35,9%, (30,7% - 41,0%) vs group B: 32,5%, (29,5% - 37,0%,) P=0.04] and median reticulocyte counts on day six (group A: 4.0%, (3.0% - 6.4%) vs group B: 3.5%, (2.1% - 4.4%), P=0.03) were significantly different between groups. There were no significant adverse events in both study groups. CONCLUSION: Erythropoietin administration significantly accelerates correction of anemia after acute ulcer bleeding.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pagonis, Thomas
- Παγώνης, Θωμάς
Subjects
dc:subject × 20- Μεθαιμορραγική αναιμία
- Οξεία αιμορραγία πεπτικού
- Ενδογενής ερυθροποιητίνη
- Ανασυνδυασμένη ανθρώπινη ερυθροποιητίνη
- Αξιολόγηση αποτελεσματικότητας - επιπλοκές
- Μεταγγίσεις αίματος
- Εφαρμογές θεραπείας με ερυθροποιητίνη
- Αύξηση ταχύτητας αποκατάστασης του αιματοκρίτη στην ΜΑΑ
- Post ulcer bleeding anaemia
- Acute upper gastrointestinal bleeding
- Erythropoetin
- Recombinant human erythropoietin
- Investigation of erythropoiesis - side effects
- Blood transfusion
- Usefulness of erythropoetin as blood conserving therapy
- Acceleration of haematocrit increase in post bleeding period
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23102